$MSEX
MIDDLESEX WATER CO Stock $msex

$msex Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000117494721000942 Filed on October 29, 2021

Income Statement

Concept	2021 Q3	2020 Q4	2020 Q3
Revenue	$39.87M	$34.63M	$39.92M
YoY Change	-0.12%	5.77%	5.7%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.353M	$5.240M	$4.721M
YoY Change	-7.79%	19.91%	11.19%
% of Gross Profit
Operating Expenses	$28.45M	$26.30M	$26.74M
YoY Change	6.38%	4.45%	3.7%
Operating Profit	$11.42M	$8.331M	$13.18M
YoY Change	-13.3%	10.21%	9.96%
Interest Expense	-$2.101M	-$1.970M	$1.906M
YoY Change	-210.23%	-13.6%	-4.51%
% of Operating Profit	-18.39%	-23.65%	14.46%
Other Income/Expense, Net	$744.0K	$350.0K	$1.390M
YoY Change	-46.47%	-42.62%	60.32%
Pretax Income	$10.41M	$6.700M	$12.67M
YoY Change	-17.82%	13.95%	16.71%
Income Tax	-$1.065M	-$1.600M	-$69.00K
% Of Pretax Income	-10.23%	-23.88%	-0.54%
Net Earnings	$11.48M	$8.307M	$12.74M
YoY Change	-9.9%	2.92%	14.55%
Net Earnings / Revenue	28.78%	23.99%	31.91%
Basic Earnings Per Share	$0.65	$0.47	$0.73
Diluted Earnings Per Share	$0.65	$0.47	$0.72
COMMON SHARES
Basic Shares Outstanding	17.49M shares	17.47M shares	17.47M shares
Diluted Shares Outstanding	17.61M shares		17.58M shares

Balance Sheet

Concept	2021 Q3	2020 Q4	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.282M	$4.500M	$5.300M
YoY Change	-0.34%	104.55%	65.63%
Cash & Equivalents	$5.282M	$4.491M	$5.346M
Short-Term Investments
Other Short-Term Assets	$13.10M	$10.00M	$12.20M
YoY Change	7.39%	4.17%	-6.15%
Inventory	$5.156M	$5.100M	$4.800M
Prepaid Expenses		$2.886M	$3.369M
Receivables	$17.03M	$14.57M	$15.57M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$40.57M	$34.12M	$37.87M
YoY Change	7.13%	17.13%	9.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$865.9M	$813.0M	$782.3M
YoY Change	10.69%	12.6%	12.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$123.1M	$84.00K	$1.367M
YoY Change	8903.51%	-95.58%	-99.14%
Total Long-Term Assets	$989.0M	$942.3M	$922.0M
YoY Change	7.27%	6.99%	8.12%
TOTAL ASSETS
Total Short-Term Assets	$40.57M	$34.12M	$37.87M
Total Long-Term Assets	$989.0M	$942.3M	$922.0M
Total Assets	$1.030B	$976.5M	$959.8M
YoY Change	7.27%	7.32%	8.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.34M	$30.44M	$24.86M
YoY Change	-30.25%	30.62%	23.07%
Accrued Expenses	$1.994M	$2.800M	$2.700M
YoY Change	-26.15%	3.7%	80.0%
Deferred Revenue
YoY Change
Short-Term Debt	$50.00M	$2.000M	$36.50M
YoY Change	36.99%	-90.0%	-37.61%
Long-Term Debt Due	$6.806M	$7.255M	$7.239M
YoY Change	-5.98%	1.07%	0.54%
Total Short-Term Liabilities	$92.49M	$56.85M	$85.35M
YoY Change	8.37%	-12.52%	-17.53%
LONG-TERM LIABILITIES
Long-Term Debt	$266.5M	$273.2M	$234.5M
YoY Change	13.64%	18.4%	2.71%
Other Long-Term Liabilities	$242.8M	$1.135M	$2.432M
YoY Change	9885.36%	-55.42%	-98.93%
Total Long-Term Liabilities	$266.5M	$274.4M	$236.9M
YoY Change	12.48%	17.6%	-47.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$92.49M	$56.85M	$85.35M
Total Long-Term Liabilities	$266.5M	$274.4M	$236.9M
Total Liabilities	$665.2M	$331.2M	$322.3M
YoY Change	106.4%	11.04%	-47.12%
SHAREHOLDERS EQUITY
Retained Earnings		$128.8M	$125.2M
YoY Change		18.49%
Common Stock		$217.5M	$216.9M
YoY Change		1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$364.4M	$348.3M	$344.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.030B	$976.5M	$959.8M
YoY Change	7.27%	7.32%	8.16%

Cashflow Statement

Concept	2021 Q3	2020 Q4	2020 Q3
OPERATING ACTIVITIES
Net Income	$11.48M	$8.307M	$12.74M
YoY Change	-9.9%	2.92%	14.55%
Depreciation, Depletion And Amortization	$4.353M	$5.240M	$4.721M
YoY Change	-7.79%	19.91%	11.19%
Cash From Operating Activities	$4.059M	$16.07M	$16.47M
YoY Change	-75.36%	26.54%	40.41%
INVESTING ACTIVITIES
Capital Expenditures	$14.75M	-$34.83M	$25.37M
YoY Change	-41.87%	24.79%	-0.61%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$14.74M	-$34.83M	-$25.37M
YoY Change	-41.88%	24.79%	-0.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.781M	990.0K	-5.050M
YoY Change	-293.68%	-78.57%	-107.57%
NET CHANGE
Cash From Operating Activities	4.059M	16.07M	16.47M
Cash From Investing Activities	-14.74M	-34.83M	-25.37M
Cash From Financing Activities	9.781M	990.0K	-5.050M
Net Change In Cash	-905.0K	-17.77M	-13.95M
YoY Change	-93.51%	67.8%	-126.36%
FREE CASH FLOW
Cash From Operating Activities	$4.059M	$16.07M	$16.47M
Capital Expenditures	$14.75M	-$34.83M	$25.37M
Free Cash Flow	-$10.69M	$50.90M	-$8.897M
YoY Change	20.11%	25.34%	-35.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000066004
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2021-11-30
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4535000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5042000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18312000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5282000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28187000	USD
	us-gaap	Contribution Of Property ContributionOfProperty	4279000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	37000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	885000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	921000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	14294000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13418000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	90000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	90000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	10079000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	7420000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37485000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15183000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5122000	USD
	us-gaap	Contribution Of Property ContributionOfProperty	3747000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5834000	USD
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1082000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1783000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17473000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	217451000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	128757000	USD
CY2020Q4	msex	Total Common Equity TotalCommonEquity	346208000	USD
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	120000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	2084000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	270182000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	277241000	USD
	us-gaap	Net Income Loss NetIncomeLoss	30118000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	921000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	575000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	7371000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	7669000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4264000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4411000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	6806000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7255000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	266483000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	273244000	USD
CY2020Q2	msex	Total Common Equity TotalCommonEquity	333373000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	12737000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	313000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	188000	USD
CY2020Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.2563
CY2020Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4475000	USD
CY2020Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	30000	USD
CY2020Q3	msex	Total Common Equity TotalCommonEquity	342106000	USD
CY2019Q4	msex	Total Common Equity TotalCommonEquity	323792000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	245000	USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.7688
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13418000	USD
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	90000	USD
	us-gaap	Stockholders Equity Other StockholdersEquityOther	37000	USD
CY2020Q3	msex	Total Common Equity TotalCommonEquity	342106000	USD
CY2021Q2	msex	Total Common Equity TotalCommonEquity	355098000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	11476000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	289000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	273000	USD
CY2021Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.2725
CY2021Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4766000	USD
CY2021Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	30000	USD
CY2021Q3	msex	Total Common Equity TotalCommonEquity	362340000	USD
CY2020Q4	msex	Total Common Equity TotalCommonEquity	346208000	USD
	us-gaap	Net Income Loss NetIncomeLoss	29305000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	885000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	81000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	245000	USD
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.8175
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14294000	USD
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	90000	USD
CY2021Q3	msex	Total Common Equity TotalCommonEquity	362340000	USD
CY2021Q3	us-gaap	Other Long Term Debt OtherLongTermDebt	148400000	USD
CY2020Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	129600000	USD
CY2021Q3	msex	Customer Advances For Construction Work CustomerAdvancesForConstructionWork	23500000	USD
CY2020Q3	msex	Customer Advances For Construction Work CustomerAdvancesForConstructionWork	23400000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	11476000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17491000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	12737000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17466000	shares
CY2021Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	30000	USD
CY2020Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	30000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11446000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17491000	shares
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12707000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17466000	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	11446000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17491000	shares
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	12707000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17466000	shares
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	11463000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17606000	shares
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	12724000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17581000	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.65
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.72
	us-gaap	Net Income Loss NetIncomeLoss	29305000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17485000	shares
	us-gaap	Net Income Loss NetIncomeLoss	30118000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17455000	shares
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	90000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	90000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29215000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17485000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30028000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17455000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.72
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29215000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17485000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	30028000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17455000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	29265000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17600000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	30078000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17570000	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.66
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.71
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2021Q3	us-gaap	Regulated And Unregulated Operating Revenue RegulatedAndUnregulatedOperatingRevenue	39874000	USD
CY2020Q3	us-gaap	Regulated And Unregulated Operating Revenue RegulatedAndUnregulatedOperatingRevenue	39920000	USD
	us-gaap	Regulated And Unregulated Operating Revenue RegulatedAndUnregulatedOperatingRevenue	109117000	USD
	us-gaap	Regulated And Unregulated Operating Revenue RegulatedAndUnregulatedOperatingRevenue	106965000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	11424000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	13177000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	26873000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	29088000	USD
	us-gaap	Net Income Loss NetIncomeLoss	30118000	USD
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14745000	USD
CY2020Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25367000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61245000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	70785000	USD
CY2021Q3	us-gaap	Assets Assets	1029592000	USD
CY2020Q4	us-gaap	Assets Assets	976470000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	50000000.0	USD
CY2021Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	60000000.0	USD
CY2021Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	110000000.0	USD
CY2021Q3	msex	Line Of Credit Facility Average Daily Amount Outstanding LineOfCreditFacilityAverageDailyAmountOutstanding	40543000	USD
CY2020Q3	msex	Line Of Credit Facility Average Daily Amount Outstanding LineOfCreditFacilityAverageDailyAmountOutstanding	35576000	USD
	msex	Line Of Credit Facility Average Daily Amount Outstanding LineOfCreditFacilityAverageDailyAmountOutstanding	22841000	USD
	msex	Line Of Credit Facility Average Daily Amount Outstanding LineOfCreditFacilityAverageDailyAmountOutstanding	31372000	USD
CY2021Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0113	pure
CY2020Q3	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0124	pure
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0114	pure
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0163	pure
CY2021Q3	us-gaap	Line Of Credit LineOfCredit	50000000.0	USD
CY2021Q3	msex	Cost Of Treated Water CostOfTreatedWater	889000	USD
CY2020Q3	msex	Cost Of Treated Water CostOfTreatedWater	933000	USD
	msex	Cost Of Treated Water CostOfTreatedWater	2641000	USD
	msex	Cost Of Treated Water CostOfTreatedWater	2657000	USD
CY2021Q3	msex	Cost Of Untreated Water CostOfUntreatedWater	841000	USD
CY2020Q3	msex	Cost Of Untreated Water CostOfUntreatedWater	878000	USD
	msex	Cost Of Untreated Water CostOfUntreatedWater	2483000	USD
	msex	Cost Of Untreated Water CostOfUntreatedWater	2530000	USD
CY2021Q3	us-gaap	Cost Of Purchased Water CostOfPurchasedWater	1730000	USD
CY2020Q3	us-gaap	Cost Of Purchased Water CostOfPurchasedWater	1811000	USD
	us-gaap	Cost Of Purchased Water CostOfPurchasedWater	5124000	USD
CY2021Q3	msex	Estimated Incremental Borrowing Rate EstimatedIncrementalBorrowingRate	0.0403	pure
CY2020Q3	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	200000	USD
CY2021Q3	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	200000	USD
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	600000	USD
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	600000	USD
CY2021Q3	msex	Right Of Use Asset At Lease Inception RightOfUseAssetAtLeaseInception	7300000	USD
CY2021Q3	msex	Right Of Use Assets Accumulated Amortization RightOfUseAssetsAccumulatedAmortization	2600000	USD
CY2021Q3	msex	Right Of Use Assets Current RightOfUseAssetsCurrent	4700000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	200000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	800000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	800000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	800000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	800000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3600000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7000000.0	USD
	msex	Wholesale Municipal Revenue WholesaleMunicipalRevenue	11079000	USD
	msex	Wholesale Municipal Revenue WholesaleMunicipalRevenue	11553000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1700000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	53000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	800000	USD
	msex	Budgeted Construction Cost BudgetedConstructionCost	77000000	USD
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	38000000	USD
	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	400000	USD
	msex	Commercial Operating Revenues CommercialOperatingRevenues	11678000	USD
CY2020Q3	msex	Industrial Operating Revenues IndustrialOperatingRevenues	2629000	USD
	msex	Industrial Operating Revenues IndustrialOperatingRevenues	6858000	USD
	msex	Industrial Operating Revenues IndustrialOperatingRevenues	6885000	USD
CY2021Q3	msex	Residential Commercial Industrial And Fire Protection Revenue ResidentialCommercialIndustrialAndFireProtectionRevenue	3171000	USD
CY2020Q3	msex	Residential Commercial Industrial And Fire Protection Revenue ResidentialCommercialIndustrialAndFireProtectionRevenue	3129000	USD
	msex	Residential Commercial Industrial And Fire Protection Revenue ResidentialCommercialIndustrialAndFireProtectionRevenue	9436000	USD
	msex	Residential Commercial Industrial And Fire Protection Revenue ResidentialCommercialIndustrialAndFireProtectionRevenue	9235000	USD
CY2021Q3	msex	Wholesale Municipal Revenue WholesaleMunicipalRevenue	3822000	USD
CY2020Q3	msex	Wholesale Municipal Revenue WholesaleMunicipalRevenue	4028000	USD
CY2021Q3	msex	Nonregualted Contract Operations Revenue NonregualtedContractOperationsRevenue	2888000	USD
CY2020Q3	msex	Nonregualted Contract Operations Revenue NonregualtedContractOperationsRevenue	3100000	USD
	msex	Nonregualted Contract Operations Revenue NonregualtedContractOperationsRevenue	9336000	USD
	msex	Nonregualted Contract Operations Revenue NonregualtedContractOperationsRevenue	9034000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	39839000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	39886000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	109007000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	106860000	USD
CY2021Q3	us-gaap	Regulated Operating Revenue Other RegulatedOperatingRevenueOther	445000	USD
CY2020Q3	us-gaap	Regulated Operating Revenue Other RegulatedOperatingRevenueOther	255000	USD
	us-gaap	Regulated Operating Revenue Other RegulatedOperatingRevenueOther	755000	USD
	us-gaap	Regulated Operating Revenue Other RegulatedOperatingRevenueOther	441000	USD
CY2021Q3	msex	Other Nonregulated Revenues OtherNonregulatedRevenues	107000	USD
CY2020Q3	msex	Other Nonregulated Revenues OtherNonregulatedRevenues	104000	USD
	msex	Other Nonregulated Revenues OtherNonregulatedRevenues	321000	USD
	msex	Other Nonregulated Revenues OtherNonregulatedRevenues	311000	USD
CY2021Q3	msex	Inter Segment Elimination Operating Revenues InterSegmentEliminationOperatingRevenues	-517000	USD
CY2020Q3	msex	Inter Segment Elimination Operating Revenues InterSegmentEliminationOperatingRevenues	-325000	USD
	msex	Inter Segment Elimination Operating Revenues InterSegmentEliminationOperatingRevenues	-966000	USD
	msex	Inter Segment Elimination Operating Revenues InterSegmentEliminationOperatingRevenues	-647000	USD
	us-gaap	Regulated And Unregulated Operating Revenue RegulatedAndUnregulatedOperatingRevenue	109117000	USD
	us-gaap	Regulated And Unregulated Operating Revenue RegulatedAndUnregulatedOperatingRevenue	106965000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	2700000	USD
CY2019	us-gaap	Interest Paid InterestPaid	100000	USD
	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	500000	USD
	us-gaap	Income Tax Examination Interest Expense IncomeTaxExaminationInterestExpense	200000	USD

Files In Submission

Name	View Source	Status
0001174947-21-000942-index-headers.html	Edgar Link	pending
0001174947-21-000942-index.html	Edgar Link	pending
0001174947-21-000942.txt	Edgar Link	pending
0001174947-21-000942-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
msex-20210930.xsd	Edgar Link	pending
msex-20210930_cal.xml	Edgar Link	unprocessable
msex-20210930_def.xml	Edgar Link	unprocessable
msex-20210930_lab.xml	Edgar Link	unprocessable
msex-20210930_pre.xml	Edgar Link	unprocessable
msex10q0921.htm	Edgar Link	pending
msex10q0921_htm.xml	Edgar Link	completed
msex10qex31-1.htm	Edgar Link	pending
msex10qex31-2.htm	Edgar Link	pending
msex10qex32-1.htm	Edgar Link	pending
msex10qex32-2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MSEX
MIDDLESEX WATER CO Stock $msex

2021 Q3 Form 10-Q Financial Statement

#000117494721000942 Filed on October 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MSEX MIDDLESEX WATER CO Stock $msex

2021 Q3 Form 10-Q Financial Statement

#000117494721000942 Filed on October 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MSEX
MIDDLESEX WATER CO Stock $msex